Thesis Abstract

Abstract
Inborn errors of metabolism are a group of rare genetic disorders that result from the deficiency or dysfunction of enzymes involved in metabolic pathways. These disorders can lead to the accumulation of toxic substances or the lack of essential compounds, disrupting normal metabolic processes. Inborn errors of metabolism can manifest with a wide range of symptoms, including developmental delays, neurological problems, organ dysfunction, and metabolic crises. Early diagnosis is crucial for the management of these conditions, as many of them are treatable with dietary modifications, enzyme replacement therapy, or specific medications. Newborn screening programs have been established in many countries to detect these disorders early and initiate appropriate interventions to prevent severe complications. Genetic testing has also played a significant role in identifying the specific genetic mutations underlying inborn errors of metabolism, allowing for more targeted treatments and personalized management strategies. Research efforts are ongoing to better understand the underlying mechanisms of these disorders and develop novel therapeutic approaches, such as gene therapy and small molecule drugs. Collaborative initiatives among clinicians, researchers, and patient advocacy groups are essential to improve the care and outcomes of individuals affected by inborn errors of metabolism. Overall, increased awareness, early detection, and advancements in treatment options are crucial for enhancing the quality of life for patients with these rare genetic disorders.

Thesis Overview